IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CYNTHIA M FULLBRIGHT

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health

NPI
1598858268
CMS profile
10867487
Location
PLANO, TX

General Payments · PY2021–2024

$3,343.86

  • Reported across 150 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,315.60

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Adult Health TX All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,315.60 50

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $346.47 17
Edwards Lifesciences Corporation $181.36 1
Itamar Medical Inc $100.91 1
Novo Nordisk AS $79.23 4
Esperion Therapeutics, Inc. $75.62 5
Merck Sharp & Dohme Corporation $68.74 3
Abbott Laboratories $68.00 1
Medtronic, Inc. $65.93 2
CVRx Inc. $60.39 2
E.R. Squibb & Sons, L.L.C. $55.72 3
Janssen Pharmaceuticals, Inc $53.06 3
Kiniksa Pharmaceuticals International, plc $51.26 2
Acerta Pharma LLC $34.90 2
PFIZER INC. $27.09 1
SANOFI-AVENTIS U.S. LLC $18.14 1
Boehringer Ingelheim Pharmaceuticals, Inc. $15.03 1
Amgen Inc. $13.75 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $333.44 18
PY2022 $859.35 39
PY2023 $835.47 43
PY2024 $1,315.60 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $68.00 05/02/2024 Food and Beverage Undisputed 01/23/2026 1125146139 CMS
Amgen Inc. $13.75 02/09/2024 Food and Beverage Undisputed 01/23/2026 1115638922 CMS
AstraZeneca Pharmaceuticals LP $20.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 1104328180 CMS
AstraZeneca Pharmaceuticals LP $14.90 08/22/2024 Food and Beverage Undisputed 01/23/2026 1105348830 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.03 08/05/2024 Food and Beverage Undisputed 01/23/2026 1118075641 CMS
CVRx, Inc. $19.48 06/13/2024 Food and Beverage Undisputed 01/23/2026 1128561562 CMS
CVRx, Inc. $40.91 07/16/2024 Food and Beverage Undisputed 01/23/2026 1128561564 CMS
E.R. Squibb & Sons, L.L.C. $13.53 06/07/2024 Food and Beverage Undisputed 01/23/2026 1101538703 CMS
E.R. Squibb & Sons, L.L.C. $18.15 07/31/2024 Food and Beverage Undisputed 01/23/2026 1101538707 CMS
E.R. Squibb & Sons, L.L.C. $24.04 12/05/2024 Food and Beverage Undisputed 01/23/2026 1101538791 CMS
Edwards Lifesciences Corporation $181.36 06/12/2024 Food and Beverage Undisputed 01/23/2026 1138839632 CMS
Esperion Therapeutics, Inc. $15.06 01/06/2024 Food and Beverage Undisputed 01/23/2026 1129466642 CMS
Esperion Therapeutics, Inc. $14.94 02/16/2024 Food and Beverage Undisputed 01/23/2026 1129466644 CMS
Esperion Therapeutics, Inc. $15.92 04/06/2024 Food and Beverage Undisputed 01/23/2026 1129466646 CMS
Esperion Therapeutics, Inc. $15.20 06/21/2024 Food and Beverage Undisputed 01/23/2026 1129466648 CMS
Esperion Therapeutics, Inc. $14.50 10/25/2024 Food and Beverage Undisputed 01/23/2026 1129466650 CMS
Itamar Medical Inc $100.91 08/19/2024 Food and Beverage Undisputed 01/23/2026 1151578119 CMS
Janssen Pharmaceuticals, Inc $19.36 02/14/2024 Food and Beverage Undisputed 01/23/2026 1078210437 CMS
Janssen Pharmaceuticals, Inc $17.44 03/20/2024 Food and Beverage Undisputed 01/23/2026 1078210697 CMS
Janssen Pharmaceuticals, Inc $16.26 04/17/2024 Food and Beverage Undisputed 01/23/2026 1078210491 CMS
Kiniksa Pharmaceuticals International, plc $27.83 05/23/2024 Food and Beverage Undisputed 01/23/2026 1154864415 CMS
Kiniksa Pharmaceuticals International, plc $23.43 08/15/2024 Food and Beverage Undisputed 01/23/2026 1154864449 CMS
Medtronic, Inc. $41.72 09/04/2024 Food and Beverage Undisputed 01/23/2026 1116967548 CMS
Medtronic, Inc. $24.21 10/21/2024 Food and Beverage Undisputed 01/23/2026 1116967550 CMS
Merck Sharp & Dohme LLC $23.89 04/04/2024 Food and Beverage Undisputed 01/23/2026 1141650373 CMS
Merck Sharp & Dohme LLC $20.96 05/16/2024 Food and Beverage Undisputed 01/23/2026 1141650371 CMS
Merck Sharp & Dohme LLC $23.89 06/20/2024 Food and Beverage Undisputed 01/23/2026 1141852821 CMS
Novartis Pharmaceuticals Corporation $12.98 02/07/2024 Food and Beverage Undisputed 01/23/2026 1086834199 CMS
Novartis Pharmaceuticals Corporation $17.43 02/23/2024 Food and Beverage Undisputed 01/23/2026 1086834201 CMS
Novartis Pharmaceuticals Corporation $4.28 02/28/2024 Food and Beverage Undisputed 01/23/2026 1086834203 CMS
Novartis Pharmaceuticals Corporation $10.67 05/01/2024 Food and Beverage Undisputed 01/23/2026 1086834205 CMS
Novartis Pharmaceuticals Corporation $26.42 05/30/2024 Food and Beverage Undisputed 01/23/2026 1086834207 CMS
Novartis Pharmaceuticals Corporation $30.00 06/27/2024 Food and Beverage Undisputed 01/23/2026 1086834209 CMS
Novartis Pharmaceuticals Corporation $17.64 07/25/2024 Food and Beverage Undisputed 01/23/2026 1086834211 CMS
Novartis Pharmaceuticals Corporation $30.71 08/05/2024 Food and Beverage Undisputed 01/23/2026 1086834213 CMS
Novartis Pharmaceuticals Corporation $21.47 08/26/2024 Food and Beverage Undisputed 01/23/2026 1086834217 CMS
Novartis Pharmaceuticals Corporation $23.22 08/28/2024 Food and Beverage Undisputed 01/23/2026 1086834219 CMS
Novartis Pharmaceuticals Corporation $33.83 09/05/2024 Food and Beverage Undisputed 01/23/2026 1086834221 CMS
Novartis Pharmaceuticals Corporation $10.35 09/11/2024 Food and Beverage Undisputed 01/23/2026 1086834215 CMS
Novartis Pharmaceuticals Corporation $30.27 09/18/2024 Food and Beverage Undisputed 01/23/2026 1086834223 CMS
Novartis Pharmaceuticals Corporation $17.61 09/23/2024 Food and Beverage Undisputed 01/23/2026 1086834225 CMS
Novartis Pharmaceuticals Corporation $23.88 10/21/2024 Food and Beverage Undisputed 01/23/2026 1086834227 CMS
Novartis Pharmaceuticals Corporation $22.39 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086834231 CMS
Novartis Pharmaceuticals Corporation $13.32 11/25/2024 Food and Beverage Undisputed 01/23/2026 1086834229 CMS
Novo Nordisk Inc $16.07 04/23/2024 Food and Beverage Undisputed 01/23/2026 1100488909 CMS
Novo Nordisk Inc $21.77 08/08/2024 Food and Beverage Undisputed 01/23/2026 1100359430 CMS
Novo Nordisk Inc $22.34 10/28/2024 Food and Beverage Undisputed 01/23/2026 1100463106 CMS
Novo Nordisk Inc $19.05 12/05/2024 Food and Beverage Undisputed 01/23/2026 1100600753 CMS
PFIZER INC. $27.09 05/02/2024 Food and Beverage Undisputed 01/23/2026 1131346387 CMS
SANOFI-AVENTIS U.S. LLC $18.14 02/27/2024 Food and Beverage Undisputed 01/23/2026 1139744570 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.